Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Toggle navigation PDFSEARCH.IO Document Search Engine - browse more than 18 million documents Sign up Sign in Propionates Find Documents Back to Results First Page Meta Content Microsoft Word NCCN AZ and Abraxis Joint Release[removed]_4_.doc Add to Reading List Document Date: 2010-06-16 09:51:35 Open Document View Document Preview and Link File Size: 50,76 KB Share Result on Facebook City Ann Arbor / San Francisco / Buffalo / Houston / Philadelphia / Memphis / Omaha / Washington / Durham / St. Louis / Seattle / Birmingham / Boston / Baltimore / Los Angeles / Nashville / Tampa / / Company First Page Meta Content Abraxis BioScience / Huntsman / AO 990 / Fox Chase / LG / Dana / AstraZeneca / / Country United States / / Currency USD / / Event Business Partnership / FDA Phase / / Facility Huntsman Cancer Institute / Memorial Sloan / University of Alabama / James Cancer Hospital / University of Utah / Roswell Park Cancer Institute / The University of Texas M / The Nebraska Medical Center / University of Michigan Comprehensive Cancer Center / Anderson Cancer Center / University School / Research Institute / Women’s Cancer Center / Solove Research Institute / Lurie Comprehensive Cancer Center of Northwestern University / Jewish Hospital / Birmingham Comprehensive Cancer Center / Kettering Cancer Center / University of Tennessee Cancer Institute / Ingram Cancer Center / UCSF Helen Diller Family Comprehensive Cancer Center / Massachusetts General Hospital Cancer Center / The Ohio State University / Fred Hutchinson Cancer Research Center / Fox Chase Cancer Center / First Page Meta Content SPARC Fort / Duke Comprehensive Cancer Center / / IndustryTerm treatment of breast cancer / cancer care / manufacturing / biotechnology / treatment of metastatic breast cancer / healthcare / pharmaceutical / tumor targeting technology / / MarketIndex FTSE4Good / Dow Jones Sustainability / / MedicalCondition ovarian cancers / dysfunction / metastatic disease / melanoma / pulmonary / pulmonary thromboembolism / diarrhea / cardiac arrest / renal dysfunction / breast cancer / tumor / cancer / arthralgia / neutropenia / vomiting / supraventricular tachycardia / infection / infectious disease / chest pain / nausea / thrombocytopenia / alopecia / metastatic breast cancer / hypersensitivity / infections / cancers / different tumor / hypertension / mucositis / thrombosis / anemia / / MedicalTreatment adjuvant chemotherapy / combination chemotherapy / / Organization First Page Meta Content University of Michigan / University of Utah / Salt Lake City / FDA / Washington University / University of Alabama at Birmingham / University of Texas / The Ohio State University / Columbus / University of Tennessee / Northwestern University / Chicago / Stanford / / Person Stanford Comprehensive / H. Lee Moffitt / Lisa Schoenberg / Patrick Soon-Shiong // Position Chairman and Chief Executive Officer / physician / Vice President of Specialty Care / arbiter / leader / / Product paclitaxel / ABRAXANE / Injectable Suspension / Abraxis BioScience / / ProvinceOrState Nebraska / Ohio / Alabama / New York / Washington / Michigan / Missouri / Utah / California / Texas / Maryland / Illinois / Tennessee / Pennsylvania / Florida / North Carolina / Massachusetts / / Technology neuroscience / tumor targeting technology / DNA Chip / gene expression / chemotherapy / biotechnology / / First Page Meta Content URL www.abraxane.com / www.nccn.org / www.astrazeneca-us.com / www.abraxisbio.com / / SocialTag Cancer organizations Benzamides Benzoates Paclitaxel Propionates Protein-bound paclitaxel Abraxis BioScience Metastatic breast cancer National Comprehensive Cancer Network Medicine time: 0.0701 sec. Designed and built with all the love in the world in Europe. © PDFSEARCH.IO 2013 Privacy | Contact Us